Since IFN treatment, including PEG-IFN, can cause medical conditions such as depression, interstitial pneumonia, diabetes mellitus, thyroid disease, leukopenia, thrombocytopenia and flu-like symptoms, its duration should preferably be minimal [21]. This evidence concerns the gene IFNA1 and Decreased total leukocyte count.